Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds RAPT Therapeutics Q3 EPS $(0.63), Same YoY

RAPT Therapeutics Q3 EPS $(0.63), Same YoY

RAPT Therapeutics (NASDAQ:RAPT) reported quarterly losses of $(0.63) per share. This is unchanged from the same period last year.

byBenzinga Newsdesk

November 10, 2022

1 minute read

RAPT Therapeutics (NASDAQ:RAPT) reported quarterly losses of $(0.63) per share. This is unchanged from the same period last year.

Former Morgan Stanley CEO James Gorman Says Bitcoin Is Not A ‘Fad’: ‘I Just Don’t Think It’s A Core Investment’

By Benzinga Neuro

January 5, 12:27 AM

The former CEO of Morgan Stanley, James Gorman, recently shared his perspective on Bitcoin (CRYPTO: BTC), the banking sector and the economic landscape.

BTC

Logitech Raises FY24 Revenue Guidance Outlook From $3.8B-$4B To $4B-$4.15B Vs $4.02B Est.

By Benzinga Newsdesk

October 23, 10:28 PM

Updated Full Year OutlookLogitech raised its full-year outlook for Fiscal Year 2024: Previous FY 2024 outlookNew FY 2024 outlookSales$3.8 - $4.0 billion$4.0 - $4.15 billionSales decline (in US dollars, year over

LOGI